255 related articles for article (PubMed ID: 8939141)
1. Use of interferon beta 1b for multiple sclerosis. Manufacturer defends the drug.
Longthorne PN
BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939141
[No Abstract] [Full Text] [Related]
2. Use of interferon beta 1b for multiple sclerosis. Importance of relapses must not be underestimated.
Cardy P
BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939142
[No Abstract] [Full Text] [Related]
3. Interferon beta in multiple sclerosis.
Richards RG
BMJ; 1996 Nov; 313(7066):1159. PubMed ID: 8916730
[No Abstract] [Full Text] [Related]
4. Treatment of multiple sclerosis with interferon beta-1 b.
Abdul-Ahad A; Shah S; Galazka A
Neurology; 1997 Aug; 49(2):641-2. PubMed ID: 9270626
[No Abstract] [Full Text] [Related]
5. Why interferon beta 1b was licensed is a mystery.
Harvey P
BMJ; 1996 Aug; 313(7052):297-8. PubMed ID: 8704553
[No Abstract] [Full Text] [Related]
6. Use of interferon beta 1b for multiple sclerosis. Patients will put up with side effects because of their desire to beat the disease.
Chellingsworth M
BMJ; 1996 Nov; 313(7067):1263. PubMed ID: 8939140
[No Abstract] [Full Text] [Related]
7. Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis.
Petkau J; White R
Mult Scler; 1997 Dec; 3(6):402. PubMed ID: 9493643
[No Abstract] [Full Text] [Related]
8. [Immunotherapy of multiple sclerosis. Consensus and controversies].
Hohlfeld R
Nervenarzt; 1999 Apr; 70(4):297. PubMed ID: 10354989
[No Abstract] [Full Text] [Related]
9. Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment.
Blake G; Murphy S
Neurology; 1997 Dec; 49(6):1747-8. PubMed ID: 9409387
[No Abstract] [Full Text] [Related]
10. Multiple sclerosis and interferon beta-1b, past, present and future.
Horowski R
Clin Neurol Neurosurg; 2002 Jul; 104(3):259-64. PubMed ID: 12127665
[No Abstract] [Full Text] [Related]
11. New onset of rheumatoid arthritis during interferon beta-1B treatment in a patient with multiple sclerosis: comment on the case report by Jabaily and Thompson.
Alsalameh S; Manger B; Kern P; Kalden J
Arthritis Rheum; 1998 Apr; 41(4):754. PubMed ID: 9550494
[No Abstract] [Full Text] [Related]
12. Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b.
Frese A; Bethke F; Lüdemann P; Stögbauer F
Neurology; 1999 Nov; 53(8):1892-3. PubMed ID: 10563657
[No Abstract] [Full Text] [Related]
13. Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients.
Morra VB; Coppola G; Orefice G; De Michele G; Vacca G; Filla A; Bonavita V
Neurology; 2004 Mar; 62(5):829-30. PubMed ID: 15007146
[No Abstract] [Full Text] [Related]
14. Anticytokine antibodies in beta interferon-treated MS patients and the need for testing: plight of the practicing neurologist.
Pachner AR
Neurology; 1997 Sep; 49(3):647-50. PubMed ID: 9305316
[No Abstract] [Full Text] [Related]
15. [Clinical efficacy and safety of long-term immunomodulating therapy with interferon beta].
Demina TL; Khachanova NV; Davydovskaia MV; Popova NF; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):24-6. PubMed ID: 18567192
[No Abstract] [Full Text] [Related]
16. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis.
Webster GF; Knobler RL; Lublin FD; Kramer EM; Hochman LR
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):365-7. PubMed ID: 8655728
[TBL] [Abstract][Full Text] [Related]
17. The significance of neutralizing antibodies in patients with multiple sclerosis treated with interferon beta.
Rice G
Arch Neurol; 2001 Aug; 58(8):1297-8. PubMed ID: 11493173
[No Abstract] [Full Text] [Related]
18. Experiences with interferon-beta-1b treatment in MS after three year follow-up.
Bencsik K; Rajda C; Füvesi J; Járdánházy T; Török M; Vécsei L
Swiss Med Wkly; 2002 May; 132(17-18):237. PubMed ID: 12087490
[No Abstract] [Full Text] [Related]
19. Nursing management of MS patients receiving interferon beta-1b therapy.
Costello K; Conway K
Rehabil Nurs; 1997; 22(2):62-6, 81. PubMed ID: 9110845
[TBL] [Abstract][Full Text] [Related]
20. The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWiST analysis.
Schwartz CE; Coulthard-Morris L; Cole B; Vollmer T
Arch Neurol; 1997 Dec; 54(12):1475-80. PubMed ID: 9400356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]